RecruitingPhase 2NCT05909150

Hypertonic Saline Solution to Prevent Acute Kidney Injury After Heart Transplantation

Use of Hypertonic Saline Solution to Prevent Acute Kidney Injury After Heart Transplantation

Sponsor

Fernando Bacal

Enrollment

74 participants

Start Date

Nov 8, 2023

Study Type

INTERVENTIONAL

Conditions

Acute Kidney Injury Heart Transplantation

Summary

The goal of this study is to evaluate if hypertonic saline solution can prevent or attenuate acute kidney injury after heart transplantation in the early postoperative phase.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Sodium chloride solution 0,9% and a drug called Sodium chloride solution 3,5% for people with acute kidney injury and heart transplantation. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGSodium chloride solution 3,5%

Patients will receive 150 mL HSS 3,5% intravenous twice daily for 3 days after heart transplantation.

DRUGSodium chloride solution 0,9%

Patients will receive 150 mL NS 0,9% intravenous twice daily for 3 days after heart transplantation.

Locations(1)

Heart Institute, University of São Paulo.

São Paulo, Brazil

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05909150

Related Trials

Influence of Human Albumin Supplementation on Kidney Dysfunction After Liver Transplantation

NCT065359458 locations

Does Urinary TIMP2 and IGFBP7 Can Identify High Risk Patients of Progression From Mild and Moderate to Severe Acute Kidney Injury During Septic Shock?

NCT035474141 location

LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery

NCT058794329 locations

UPTAKE: Using Personalized Risk and Digital Tools to Guide Transitions Following Acute Kidney Events

NCT058066452 locations

Labile Iron Removal by Adding the Iron Chelator MEX-CD1 to Dialysate in Sepsis-Associated Acute Kidney Injury

NCT072364632 locations